Danderyd, Sweden

Joakim Mihkel Tedroff

This inventor holds 1 USPTO granted patent and 3 published patent applications and 2 EPO patents. Top assignee: Irl 790 Ab. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joakim Mihkel Tedroff. Retrieved from https://idiyas.com/inventor/joakim-mihkel-tedroff

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Biography of Joakim Mihkel Tedroff

Introduction

Joakim Mihkel Tedroff is an accomplished inventor based in Danderyd, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds.

Latest Patents

Tedroff holds a patent for "Pharmaceutically acceptable salts of [2-(3-fluoro-5-methane-sulfonylphenoxy)ethyl](propyl)amine and uses thereof." This patent discloses a salt of Formula III, along with a method for its manufacturing and various applications.

Career Highlights

Throughout his career, Tedroff has focused on innovative solutions in the pharmaceutical industry. His work has led to advancements that may improve therapeutic options for patients.

Collaborations

Tedroff collaborates with notable colleagues, including Inese Reine and Clas Sonesson. Together, they contribute to research and development efforts within their organization.

Conclusion

Joakim Mihkel Tedroff's work exemplifies the spirit of innovation in the pharmaceutical sector. His contributions continue to impact the field positively, showcasing the importance of research and collaboration in driving advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…